The biochemistry of the basal ganglia and Parkinson's disease.

about

α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.A comparison of facial emotion processing in neurological and psychiatric conditions.Physiology of abnormal movements.Fusaric acid induces a notochord malformation in zebrafish via copper chelation.

P2860

Q35264378-0DD878A8-11F5-486D-96E1-0CA05A5724A6 Q35866967-BB1D3393-99E0-4E60-B1C3-1FB4A2F73AF5 Q39717255-7E303830-29F2-4385-900F-35669CC7A111 Q41285365-1F519DE9-5560-440B-A6F2-6D6BC4809876

P2860

The biochemistry of the basal ganglia and Parkinson's disease.

Item

http://www.wikidata.org/entity/Q38161004

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The biochemistry of the basal ganglia and Parkinson's disease.

@en

type

Item

label

The biochemistry of the basal ganglia and Parkinson's disease.

@en

prefLabel

The biochemistry of the basal ganglia and Parkinson's disease.

@en

P1476

The biochemistry of the basal ganglia and Parkinson's disease.

@en

P2093

Curzon G

http://www.w3.org/2001/XMLSchema#string

P2860

[Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Picrotoxin antagonism of gamma-aminobutyric acid inhibitory responses and synaptic inhibition in the rat substantia nigra.

The brain-stem lesions in Parkinsonism.

The neurochemistry of Parkinson's disease: effect of L-dopa therapy.

Immunohistochemical localization of choline acetyltransferase containing neostriatal neurons and their relationship with dopaminergic synapses.

Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea.

Dopamine acetylcholine imbalance in Parkinson's disease. Possible regenerative overgrowth of cholinergic axon terminals.

Parkinson's disease: from brain homogenate to treatment.

Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.

Role of noradrenaline in levodopa reversal of reserpine akinesia.

P304

719-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1136/PGMJ.53.626.719

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

626

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1977-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23109844

http://www.w3.org/2001/XMLSchema#string

P698

24209

http://www.w3.org/2001/XMLSchema#string

P932

2496787

http://www.w3.org/2001/XMLSchema#string

The biochemistry of the basal ganglia and Parkinson's disease.

about

P2860

P2860

The biochemistry of the basal ganglia and Parkinson's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932